Hepatosplenic αβ T-cell lymphoma successfully treated with allogeneic bone marrow transplantation [4]

Bone Marrow Transplantation

Volumn 39, Issue 8, 2007, Pages 513-514

  Machino, T ^a   Okoshi, Y ^a   Kaneko, S ^a   Obara, N ^a   Mukai, H Y ^a   Suzukawa, K ^a   Hasegawa, Y ^a   Yamashita, Y ^b   Mori, N ^b   Kojima, H ^a   Nagasawa, T ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; INTERLEUKIN 2 RECEPTOR; METHOTREXATE; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT; LEUKOCYTE ANTIGEN;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; CHROMOSOME ANALYSIS; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE ESCALATION; DRUG MEGADOSE; ENGRAFTMENT; FEVER; GENE REARRANGEMENT; GENOME ANALYSIS; GRAFT VERSUS HOST REACTION; HEPATOSPLENIC ALPHA BETA T CELL LYMPHOMA; HEPATOSPLENOMEGALY; HLA MATCHING; HUMAN; IMMUNOPHENOTYPING; JAPANESE; LETTER; LEUKOCYTOSIS; LEUKOPENIA; LIVER DYSFUNCTION; LYMPHOCYTIC INFILTRATION; MALE; MYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOUTHERN BLOTTING; T CELL LYMPHOMA; THROMBOCYTOPENIA; TREATMENT RESPONSE; WHOLE BODY RADIATION; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; IMMUNOLOGY; MULTIMODALITY CANCER THERAPY;

ADULT; ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; HUMANS; LYMPHOMA, T-CELL; MALE; TRANSPLANTATION, HOMOLOGOUS;

EID: 34247236250     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705615     Document Type: Letter

References (9)

1. Farcet JP, Gaulard P, Marolleau JP, Le Couedic JP, Henni T, Gourdin MF et al. Hepatosplenic T-cell lymphoma: Sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood 1990; 75: 2213-2219.
2. Gaulard P, Bourquelot P, Kanavaros P, Haioun C, Le Couedic JP, Divine M et al. Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas. Am J Pathol 1990; 137 617-628.
3. Belhadj K, Reyes F, Farcet JP, Tilly H, Bastard C, Angonin R et al. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: Report on a series of 21 patients. Blood 2003; 102: 4261-4269.
4. Weidmann E. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 2000; 14: 991-997.
5. Macon WR, Levy NB, Kurtin PJ, Salhany KE, Elkhalifa MY, Casey TT et al. Hepatosplenic alphabeta, T-cell lymphomas: A report of 14 cases and comparison with hepatosplenic gamma-delta T-cell lymphomas. Am J Surg Pathol 2001; 25: 285-296.
6. Cooke CB, Krenacs L, Stetler-Stevenson M, Greiner TC, Raffeld M, Kingma DW et al. Hepatosplenic T-cell lymphoma: A distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood 1996; 88: 4265-4274.
7. Gassas A, Kirby M, Weitzman S, Ngan B, Abla O, Doyle JJ. Hepatosplenic gammadelta T-cell lymphoma in a 10-year-old boy successfully treated with hematopoietic stem cell transplantation. Am J Hematol 2004; 75: 113-114.
8. Ooi J, Iseki T, Adachi D, Yamashita T, Tomonari A, Tojo A et al. Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma. Haematologica 2001; 86: E25.
9. Sakai R, Fujisawa S, Fujimaki K, Kanamori H, Ishigatsubo Y. Long-term remission in a patient with hepatosplenic gamma-delta T cell lymphoma after cord blood stem cell transplantation following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2006; 37: 537-538.